tryptophan has been researched along with E coli Infections in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correia, MSP; Globisch, D; Joffré, E; Nookaew, I; Sasse, S; Sjöling, Å; Xiao, X; Zhu, B | 1 |
| Cao, Y; Ding, W; Lei, LH; Li, YF; Ma, JM; Peng, XP; Sun, J; Zhang, J; Zhao, J | 1 |
| Kim, JC; Mansfield, JP; Miller, DW; Pluske, JR; Sterndale, SO | 1 |
| Bao, L; Feng, L; Fu, Y; Hao, H; Hu, X; Qiu, M; Wu, K; Zhang, N; Zhao, C | 1 |
| Fairlamb, IJ; Lynam, JM; Moir, J; Ward, JS | 1 |
| Capozzalo, MM; de Lange, CF; Hampson, DJ; Hansen, CF; Htoo, JK; Kim, JC; Mullan, BP; Pluske, JR; Resink, JW; Stumbles, PA | 2 |
| Kenzaka, T | 1 |
| Bosi, P; Casini, L; De Filippi, S; Lalatta-Costerbosa, G; Mazzoni, M; Melchior, D; Minieri, L; Trevisi, P | 1 |
| Chong, VH; Pillai, BP; Yong, AM | 1 |
| Anderson, M; Evdokimov, A; Fennell, K; Fisher, DA; Smith, JF; Voznesensky, I | 1 |
| Bosi, P; Messori, S; Priori, D; Simongiovanni, A; Trevisi, P | 1 |
| Fahrner, A; Kapiotis, S; Röggla, G | 1 |
| Akpolat, N; Aygen, E; Bülbüller, N; Doğru, O; Ozdarendeli, A; Pektaş, B | 1 |
| Mireles-Cabodevila, E; Vallejo-Manzur, F; Varon, J | 1 |
| Khan, GA; Scott, AJ | 1 |
1 review(s) available for tryptophan and E coli Infections
| Article | Year |
|---|---|
Effect of
Topics: Animal Feed; Animals; Diarrhea; Diet, Protein-Restricted; Dietary Proteins; Enteropathogenic Escherichia coli; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Gastrointestinal Microbiome; Humans; Intestinal Absorption; Intestinal Mucosa; Milk Proteins; Shiga-Toxigenic Escherichia coli; Tryptophan | 2020 |
2 trial(s) available for tryptophan and E coli Infections
| Article | Year |
|---|---|
Effect of increasing the dietary tryptophan to lysine ratio on plasma levels of tryptophan, kynurenine and urea and on production traits in weaner pigs experimentally infected with an enterotoxigenic strain of Escherichia coli.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Bacterial Shedding; Body Weight; Diarrhea; Diet; Dose-Response Relationship, Drug; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Feces; Kynurenine; Lysine; Swine; Swine Diseases; Tryptophan; Urea | 2015 |
An increased ratio of dietary tryptophan to lysine improves feed efficiency and elevates plasma tryptophan and kynurenine in the absence of antimicrobials and regardless of infection with enterotoxigenic Escherichia coli in weaned pigs.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Diet; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Female; Kynurenine; Lysine; Male; Swine; Swine Diseases; Tryptophan | 2012 |
13 other study(ies) available for tryptophan and E coli Infections
| Article | Year |
|---|---|
Analysis of Growth Phases of Enterotoxigenic Escherichia coli Reveals a Distinct Transition Phase before Entry into Early Stationary Phase with Shifts in Tryptophan, Fucose, and Putrescine Metabolism and Degradation of Neurotransmitter Precursors.
Topics: Adult; Child; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fucose; Humans; Indoles; Iron; Neurotransmitter Agents; Putrescine; Tryptophan | 2022 |
Increasing dietary tryptophan in conjunction with decreasing other large neutral amino acids increases weight gain and feed intake in weaner pigs regardless of experimental infection with enterotoxigenic Escherichia coli.
Topics: Amino Acids, Neutral; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Diet; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Infections; Male; Serotonin; Swine; Swine Diseases; Tryptophan; Weight Gain | 2020 |
Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.
Topics: Animals; Escherichia coli; Escherichia coli Infections; Female; Gastrointestinal Microbiome; Limosilactobacillus reuteri; Mastitis; Mice; Probiotics; Receptors, Aryl Hydrocarbon; Tryptophan | 2021 |
Visible-light-induced CO release from a therapeutically viable tryptophan-derived manganese(I) carbonyl (TryptoCORM) exhibiting potent inhibition against E. coli.
Topics: Animals; Anti-Bacterial Agents; Carbon Monoxide; Cell Line; Coordination Complexes; Escherichia coli; Escherichia coli Infections; Humans; Light; Manganese; Mice; Models, Molecular; Tryptophan | 2014 |
Purple urine bag syndrome in a patient with a urethral balloon catheter and a history of ileal conduit urinary diversion.
Topics: Aged; Anti-Bacterial Agents; Bacteria; Catheter-Related Infections; Color; Equipment Design; Escherichia coli Infections; Female; Humans; Intestines; Pigments, Biological; Treatment Outcome; Tryptophan; Urinary Bladder Neoplasms; Urinary Catheterization; Urinary Catheters; Urinary Diversion; Urinary Tract Infections; Urine | 2015 |
A tryptophan-enriched diet improves feed intake and growth performance of susceptible weanling pigs orally challenged with Escherichia coli K88.
Topics: Animals; Antibodies, Bacterial; Bacterial Adhesion; Diet; Dietary Supplements; Disease Susceptibility; Eating; Escherichia coli; Escherichia coli Infections; Feces; Immunoglobulin A; Intestines; Swine; Tryptophan; Weaning; Weight Gain | 2009 |
Purple urine bag syndrome.
Topics: Aged; Antidepressive Agents, Second-Generation; Escherichia coli Infections; Fatal Outcome; Female; Humans; Indigo Carmine; Indoles; Tryptophan; Urinary Catheterization; Urinary Tract Infections | 2009 |
New kinase regulation mechanism found in HipBA: a bacterial persistence switch.
Topics: Anti-Bacterial Agents; Binding Sites; Crystallization; Crystallography, X-Ray; DNA-Binding Proteins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Genes, Switch; Humans; Mercury; Operon; Protein Conformation; Protein Kinase Inhibitors; Structure-Activity Relationship; Tryptophan | 2009 |
Effect of susceptibility to enterotoxigenic Escherichia coli F4 and of dietary tryptophan on gut microbiota diversity observed in healthy young pigs.
Topics: Animals; Bacterial Adhesion; beta-Galactoside alpha-2,3-Sialyltransferase; Denaturing Gradient Gel Electrophoresis; Diet; Disease Susceptibility; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Female; Intestinal Mucosa; Intestines; Jejunum; Male; Microbiota; Mucin-4; RNA, Ribosomal, 16S; Sialyltransferases; Sus scrofa; Swine; Swine Diseases; Tryptophan; Weaning | 2013 |
A case of purple urine bag syndrome (PUBS).
Topics: Aged; Aged, 80 and over; Bacteriuria; Color; Escherichia coli; Escherichia coli Infections; Humans; Indican; Proteus Infections; Proteus mirabilis; Tryptophan; Urinary Catheterization | 2002 |
The effect of L-tryptophan on hemorrhagic shock induced bacterial translocation.
Topics: Animals; Bacterial Translocation; DNA, Bacterial; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Intestines; Rabbits; Shock, Hemorrhagic; Tryptophan | 2005 |
Purple urine bag syndrome.
Topics: Aged; Anti-Bacterial Agents; Catheters, Indwelling; Escherichia coli; Escherichia coli Infections; Humans; Indican; Male; Syndrome; Treatment Outcome; Tryptophan; Ultrasonography; Urinary Bladder Neck Obstruction; Urinary Catheterization; Urinary Tract Infections | 2005 |
Partial biliary obstruction with cholangitis producing a blind loop syndrome.
Topics: Bile; Bile Acids and Salts; Biliary Tract Diseases; Cholangitis; Cholelithiasis; Cholestasis; Chromatography, Thin Layer; Escherichia coli Infections; Gallstones; Humans; Tryptophan; Vitamin B 12 | 1968 |